|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
H3: analysis of the axium prime coil (lot no.B054034) found that the axium prime pusher proximal end was broken with the release wire extending.The axium prime pusher was found bent at the hypotube break indicator (hbi).The pusher tack welds were found intact.The release wire coin was found pulled back from the lumen stop and the shield coil was found intact.The implant coil was not found still attached to the pusher.The implant coil was not returned.During analysis, an attempt was made to pull the release wire out for evaluation of the coin; however, the release wire became stuck at the broke end.Therefore, the release wire coin could not be evaluated.The shield coil was removed, the inner diameter (id) of the retainer ring was found to be visually acceptable.The retainer ring id was measured to be 0.0049¿ which is not within specification (specification:.00455" ±.00010).No other anomalies were observed.Based on the device analysis and reported information, the customer¿s reports of ¿coil resistance/stuck in catheter¿ and ¿coil kink/damage¿ could not be confirmed as the implant coil was not returned.Advancing the axium prime coil against resistance would likely result in damage to the implant coil.Possible causes of coil resistance in catheter include lack of hydration before procedure, user does not maintain continuous flush, and tortuous anatomy.The axium prime coil was prepared prior to use (which includes coil hydration), and the patient¿s vessel tortuosity was ¿minimal¿.However, information regarding if a continuous flush was maintained was not reported.Therefore, the cause could not be determined.Regarding the customer¿s report of ¿premature detachment¿ the issue was confirmed.The implant coil was not returned; therefore, analysis could not be performed and conformance to specification could not be assessed.Premature detachment can occur if the coil is advanced against resistance.In addition, it is possible the retainer ring inner diameter contributed to the event.However, the root cause could not be determined.H6: method code updated to b19.Result code updated to c0702, c070601, and c070603.Conclusion code updated to d15.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|